|
Code
|
0429C
|
|
MA number
|
EU/1/16/1109/001
|
|
Product Form:
|
plc ifc 10x2 g/0,5 (liek.inj.skl.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
Pfizer Ireland Pharmaceuticals, Ireland
|
|
Therapeutic Class:
|
15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J01 |
ANTIBACTERIALS FOR SYSTEMIC USE |
| J01D |
OTHER BETA-LACTAM ANTIBACTERIALS |
| J01DD |
Third-generation cephalosporins |
| J01DD52 |
Ceftazidime, combinations |
|
|
Shelf life:
|
36 |
|
Container:
|
glass vial
|
|
Route of admin.:
|
Intravenous use
|
European Medicines Agency's database
